Analyst Price Targets — CNTY
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 13, 2026 7:05 pm | Jeffrey Stantial | Stifel Nicolaus | $2.50 | $1.31 | StreetInsider | Century Casinos (CNTY) PT Lowered to $2.50 at Stifel |
| March 13, 2026 1:15 pm | Jeffrey Stantial | Stifel Nicolaus | $3.00 | $1.38 | StreetInsider | Stifel Reiterates Buy Rating on Century Casinos (CNTY) following Q4 report |
| October 21, 2025 11:28 am | Jeffrey Stantial | Stifel Nicolaus | $4.00 | $2.31 | StreetInsider | Stifel Reiterates Century Casinos (CNTY) at Buy Rating on Constructive Outlook |
| July 18, 2025 8:47 am | Jordan Bender | JMP Securities | $3.00 | $2.55 | StreetInsider | Citizens JMP Reiterates Market Outperform Rating on Century Casinos (CNTY) |
| November 5, 2024 7:56 am | Jordan Bender | JMP Securities | $5.00 | $4.03 | StreetInsider | JMP Securities Upgrades Century Casinos (CNTY) to Market Outperform |
| August 8, 2022 9:38 am | — | Stifel Nicolaus | $13.00 | $8.25 | Benzinga | Stifel Maintains Buy on Century Casinos, Lowers Price Target to $13 |
Latest News for CNTY
PHILADELPHIA, July 09, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century', NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases, including type 1 diabetes (T1D), and cancer, today announced that its abstracts have been accepted for oral presentations at two upcoming scientific congresses:
Century Casinos (CNTY) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Here is how Century Casinos (CNTY) and Carter's (CRI) have performed compared to their sector so far this year.
PHILADELPHIA, June 08, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century', NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases, including type 1 diabetes (T1D), and cancer, today announced the presentation of new preclinical data from CNTY-813, Century's iPSC-derived islet replacement therapy engineered with Allo-Evasion™…
COLORADO SPRINGS, Colo., May 13, 2026 /PRNewswire/ -- Century Casinos, Inc. (the "Company" or "Century Casinos") (Nasdaq Capital Market®: CNTY) announced today that Lyle Randolph, a long-term regional Vice President and General Manager of the Company, will take over as Executive Vice President of Operations for the United States.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CNTY.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.